All Stories

  1. Exploring the Synthesis, Anti-Inflammatory and Anti-Tumor Potential of 4-Maleimidylphenyl-Hydrazide Derivatives
  2. Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial–Mesenchymal Transition in Human Breast Cancer Cells
  3. Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial-Mesenchymal Transition in Human Breast Cancer Cells
  4. Synthesis and anticancer properties of a hybrid molecule with the testosterone and estradiol head-groups
  5. Investigating a new C2-symmetric testosterone dimer and its dihydrotestosterone analog: Synthesis, antiproliferative activity on prostate cancer cell lines and interaction with CYP3A4
  6. Synthesis of new para-aminobenzoic acid derivatives, in vitro biological evaluation and preclinical validation of DAB-2-28 as a therapeutic option for the treatment of bladder cancer
  7. Structural Characterization of Cis– and Trans–Pt(NH3)2Cl2 Conjugations with Chitosan Nanoparticles
  8. Design of novel 4-maleimidylphenyl-hydrazide molecules displaying anti-inflammatory properties: Refining the chemical structure
  9. Innovative C-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4
  10. Recent Advances in the Use of the Dimerization Strategy as a Means to Increase the Biological Potential of Natural or Synthetic Molecules
  11. Locating the binding sites of two aminobenzoic acid derivatives on tRNA: drug binding efficacy and RNA structure
  12. Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
  13. Binding efficacy of aminobenzoic acid derivatives with DNA duplex: drug binding sites and DNA structure and dynamics
  14. Biomolecular study and conjugation of two para-aminobenzoic acid derivatives with serum proteins: drug binding efficacy and protein structural analysis
  15. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity
  16. Complexation of cis-Pt and trans-Pt(NH3)2Cl2 with serum proteins: A potential application for drug delivery
  17. How to utilize academic research efforts in cancer drug discovery
  18. Cloning and characterization of norbelladine synthase catalyzing the first committed reaction in Amaryllidaceae alkaloid biosynthesis
  19. Testo and testo-Pt(II) bind DNA at different locations
  20. Location of multiple binding sites for testo and testo–Pt(II) with tRNA
  21. Conjugation of testo and testo-Pt(II) with serum proteins: Loading efficacy and protein conformation
  22. PAMAM dendrimers in drug delivery: loading efficacy and polymer morphology
  23. Effect of testosterone and its aliphatic and aromatic dimers on DNA morphology
  24. Testosterone and its dimers alter tRNA morphology
  25. Synthesis of novel C2-symmetric testosterone dimers and evaluation of antiproliferative activity on androgen-dependent and -independent prostate cancer cell lines
  26. Review on the delivery of steroids by carrier proteins
  27. An overview on the delivery of antitumor drug doxorubicin by carrier proteins
  28. Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity
  29. The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4
  30. An overview of molecular hybrids in drug discovery
  31. Transporting testosterone and its dimers by serum proteins
  32. Exploring the Synthesis and Anticancer Potential of L-Tyrosine-Platinum(II) Hybrid Molecules
  33. New Testosterone Derivatives as Semi-Synthetic Anticancer Agents Against Prostate Cancer: Synthesis and Preliminary Biological Evaluation
  34. Encapsulation of testosterone and its aliphatic and aromatic dimers by milk beta-lactoglobulin
  35. Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells
  36. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications
  37. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure–activity relationships and biological evaluation
  38. Steroid-linked nitrogen mustards as potential anticancer therapeutics: A review
  39. tRNA Binding to Antitumor Drug Doxorubicin and Its Analogue
  40. ERα-Targeted Therapy in Ovarian Cancer Cells by a Novel Estradiol-Platinum(II) Hybrid
  41. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone–chlorambucil hybrid designed for the treatment of prostate cancer
  42. Advances in the development of hybrid anticancer drugs
  43. Antibiotic doxorubicin and its derivative bind milk β-lactoglobulin
  44. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer
  45. Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins
  46. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines
  47. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues
  48. SAR study of tyrosine–chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines
  49. Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: Comparative molecular modeling study of three distinct families of hybrids
  50. Synthesis of d- and l-tyrosine-chlorambucil analogs active against breast cancer cell lines
  51. Evaluation of in vivo biological activities of tetrapyrrole ethanolamides as novel anticancer agents
  52. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells
  53. Design, synthesis and biological evaluation of estradiol–chlorambucil hybrids as anticancer agents
  54. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo
  55. Functionalization of Testosterone at Position 7α and Synthesis of 7α-(3-Methoxypropyl)-4-androsten-17β-ol-3-one
  56. Pure N-Alkylaminopropionic Acid and N-Alkylaminodipropionic Acid Sodium Salts: Synthesis, Characterization, and Physicochemical Properties
  57. Errata
  58. Study of DNA Interactions with Steroidal and Nonsteroidal Estrogen–Platinum (II)–Based Anticancer Drugs
  59. Simple and Efficient Synthesis of Steroidal Hybrids of Estrogen and Vitamin D3
  60. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta
  61. Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes
  62. Transfer RNA Bindings to Antitumor Estradiol-Platinum(II) Hybrid and Cisplatin
  63. Synthesis of 17β-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines
  64. DNA Interaction with Novel Antitumor Estradiol–Platinum(II) Hybrid Molecule: A Comparative Study with Cisplatin Drug
  65. Preparation and in vitro biological evaluation of tetrapyrrole ethanolamide derivatives as potential anticancer agents
  66. A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells
  67. Synthesis and Preliminary Biological Evaluation of Estrone Dimers
  68. A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468
  69. Synthesis of Substituted Triarylpyran through an Unexpected Intramolecular Cyclization
  70. Synthesis of unique 17β-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines
  71. Natural and Synthetic Biologically Active Dimeric Molecules: Anticancer Agents, Anti-HIV Agents, Steroid Derivatives and Opioid Antagonists
  72. Synthesis of 17β-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells
  73. Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers—molecular modeling studies
  74. Synthesis of 17β-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines
  75. A facile synthesis of C2-symmetric 17β-estradiol dimers
  76. Synthesis and Preliminary in Vitro Cytotoxic Activity of New Triphenylethylene Dimers
  77. Ionic Characterization of a Synthetic Amphoteric Surfactant:  N,N-((Butyloxy)propyl)amino Diacetic Acid
  78. Unexpected Transesterification of N-(Trifluoroacetyl) Doxorubicin with Acetylsalicylic Acid: Formation of 4′-O-Acetyl-N-(trifluoroacetyl) Doxorubicin
  79. Effects of New Triphenylethylene Platinum(II) Complexes on the Interaction with Phosphatidylcholine Liposomes.
  80. The synthesis and characterization of new triphenylethylene platinum(II) complexes
  81. Conjugation of doxorubicin to monoclonal anti-carcinoembryonic antigen antibody via novel thiol-directed cross-linking reagents
  82. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro
  83. Synthesis and in vitro biological evaluation of new triphenylethylene platinum (II) complexes
  84. Synthesis and preliminary in vitro biological activity of non-steroidal cytotoxic estrogens designed for the treatment of breast cancer
  85. The synthesis of new platinum(II) complexes linked to non-steroidal estrogens
  86. Synthesis of New N-(Trifluoroacetyl) Doxorubicin Analogues
  87. A stereocontrolled intramolecular cycloaddition – sigmatropic rearrangement approach to a tricyclo[7.4.01,6.01,10]tridecane precursor for (±) gascardic acid
  88. Synthesis and transannular Diels–Alder reaction of a 13-membered macrocyclic triene having a tetrasubstituted enol ether as dienophile
  89. An intramolecular cycloaddition-sigmatropic rearrangement approach to (±) gascardic acid
  90. Intramolecular Diels–Alder reactions of cyclopentadiene systems: Model studies for the total synthesis of the capnellenes
  91. Synthesis and transannular diels-alder reaction of a 13-membered macrocyclic triene having a tetrasubstituted enol ether as a dienophile
  92. 1,5-Acyclic stereoselection. The stereocontrolled synthesis of optically active vitamin E fourteen-carbon side chain alcohol
  93. Asymmetric induction on the Schiff bases